Drug Shortage Report for XARELTO

Last updated on 2021-09-15 History
Report ID 144273
Drug Identification Number 02510162
Brand name XARELTO
Common or Proper name Rivaroxaban Granules
Company Name BAYER INC
Market Status MARKETED
Active Ingredient(s) RIVAROXABAN
Strength(s) 51.7MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL
Packaging size 100 ML
ATC code B01AF
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-09-20
Actual start date 2021-09-14
Estimated end date 2021-10-30
Actual end date
Shortage status Actual shortage
Updated date 2021-09-15
Company comments
Health Canada comments
Contact Address 2920 MATHESON BLVD EAST
MISSISSAUGA, ONTARIO
CANADA L4W 5R6
Company contact information 1-800-265-7382

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-08-17 English Compare
v2 2021-08-17 French Compare
v3 2021-09-02 English Compare
v4 2021-09-02 English Compare
v5 2021-09-02 French Compare
v6 2021-09-10 English Compare
v7 2021-09-10 French Compare
v8 2021-09-14 English Compare
v9 2021-09-14 French Compare
v10 2021-09-15 English Compare